Earnings Summary: Conmed Q4

Comments
Loading...

The earnings results for Conmed CNMD for Q4 were made public on Wednesday, February 5, 2025 at 04:05 PM.

Here's a comprehensive overview of the announcement.

Earnings

Conmed beat estimated earnings by 12.0%, reporting an EPS of $1.34 versus an estimate of $1.2.

Revenue was up $18.90 million from the same period last year.

Past Earnings Performance

During the previous quarter, the company beat on EPS by $0.06, leading to a 5.0% increase share price change the next day.

Here's a look at Conmed's past performance:

Quarter Q3 2024 Q2 2024 Q1 2024 Q4 2023
EPS Estimate 0.99 0.91 0.74 1.11
EPS Actual 1.05 0.98 0.79 1.06
Revenue Estimate 318.13M 332.32M 306.78M 332.20M
Revenue Actual 316.70M 332.10M 312.27M 327.05M

To track all earnings releases for Conmed visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Overview Rating:
Speculative
50%
Technicals Analysis
66
0100
Financials Analysis
40
0100
Overview
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!